Skip to content

Menu

About Us
Our Science
Newsroom
- Press Releases
- Events & Presentations
Investor Relations
Contact

Close Menu

July 10, 2023

Panbela Announces Preliminary Safety Analysis for ASPIRE Trial

July 10, 2023

Panbela Announces Preliminary Safety Analysis for ASPIRE Trial

View/download press release »

Sign up to receive press releases via email

Leave this field empty if you're human:

Quick Links

Home
About Us
Our Science
Newsroom
Investor Relations
Contact

Contact

ir@panbela.com

Sign up to receive press releases via email:

Leave this field empty if you're human:

News & Events

Panbela Provides Business Update and Reports Q3 2024 Financial Results

Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center

Copyright ©2025 Panbela Therapeutics, Inc. All Rights Reserved.